NanoVibronix, Inc. – NASDAQ:NAOV

NanoVibronix stock price today

$5.82
+5.23
+903.1%
Financial Health
0
1
2
3
4
5
6
7
8
9

NanoVibronix stock price monthly change

-23.63%
month

NanoVibronix stock price quarterly change

-23.63%
quarter

NanoVibronix stock price yearly change

-48.21%
year

NanoVibronix key metrics

Market Cap
2.09M
Enterprise value
2.45M
P/E
-0.73
EV/Sales
1.50
EV/EBITDA
-0.41
Price/Sales
2.69
Price/Book
1.39
PEG ratio
0.02
EPS
-1.70
Revenue
2.85M
EBITDA
-2.96M
Income
-3.20M
Revenue Q/Q
160.16%
Revenue Y/Y
241.72%
Profit margin
-359.91%
Oper. margin
-356.91%
Gross margin
44.44%
EBIT margin
-356.91%
EBITDA margin
-104.14%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

NanoVibronix stock price history

NanoVibronix stock forecast

NanoVibronix financial statements

NanoVibronix, Inc. (NASDAQ:NAOV): Profit margin
Jun 2023 294K -1.07M -365.31%
Sep 2023 458K -727K -158.73%
Dec 2023 1.17M -813K -69.07%
Mar 2024 921K -588K -63.84%
NanoVibronix, Inc. (NASDAQ:NAOV): Debt to assets
Jun 2023 3831000 2.66M 69.59%
Sep 2023 7361000 2.67M 36.29%
Dec 2023 6674000 2.68M 40.25%
Mar 2024 6235000 2.73M 43.8%
NanoVibronix, Inc. (NASDAQ:NAOV): Cash Flow
Jun 2023 -1.22M 0 0
Sep 2023 -682K -3.49M 4.21M
Dec 2023 -491K 3.49M 0
Mar 2024 -579K -1K 0

NanoVibronix alternative data

NanoVibronix, Inc. (NASDAQ:NAOV): Employee count
Aug 2023 9
Sep 2023 9
Oct 2023 9
Nov 2023 9
Dec 2023 9
Jan 2024 9
Feb 2024 9
Mar 2024 9
Apr 2024 9
May 2024 10
Jun 2024 10
Jul 2024 10

NanoVibronix other data

1.35% -8.00%
of NAOV is owned by hedge funds
17.04K -100.67K
shares is hold by hedge funds

NanoVibronix, Inc. (NASDAQ:NAOV): Insider trades (number of shares)
Period Buy Sel
Jun 2022 46000 0
Jan 2023 50000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
MIKA THOMAS director
Common Stock 50,000 $0.25 $12,500
Purchase
FASHEK CHRISTOPHER M director
Common Stock 40,000 $0.6 $23,840
Purchase
BROWN STEPHEN RUSSELL officer: Chief Financial Officer
Common Stock 4,000 $0.57 $2,296
Purchase
CASSIRER AURORA director
Common Stock 2,000 $0.69 $1,380
Purchase
FASHEK CHRISTOPHER M director
Common Stock 10,000 N/A N/A
Insider Compensation
Mr. Brian M. Murphy (1957) Chief Executive Officer & Director $321,000
Mr. Stephen R. Brown CPA, CPA (1956) Chief Financial Officer & Accounting Officer
$207,500
Wednesday, 9 October 2024
businesswire.com
Monday, 23 September 2024
businesswire.com
Wednesday, 22 May 2024
businesswire.com
Thursday, 16 May 2024
businesswire.com
Tuesday, 14 May 2024
businesswire.com
Wednesday, 24 April 2024
Accesswire
Tuesday, 7 November 2023
PennyStocks
Tuesday, 29 November 2022
InvestorPlace
Saturday, 24 September 2022
PennyStocks
Wednesday, 14 September 2022
Business Wire
Wednesday, 30 March 2022
PennyStocks
InvestorPlace
Benzinga
Tuesday, 21 December 2021
Benzinga
Tuesday, 12 October 2021
PennyStocks
Monday, 11 October 2021
Benzinga
Pulse2
GlobeNewsWire
Wednesday, 29 September 2021
GlobeNewsWire
Sunday, 26 September 2021
PennyStocks
Tuesday, 14 September 2021
GlobeNewsWire
Wednesday, 1 September 2021
Seeking Alpha
Friday, 27 August 2021
PennyStocks
Wednesday, 25 August 2021
PennyStocks
Monday, 23 August 2021
InvestorPlace
Saturday, 21 August 2021
PennyStocks
Tuesday, 17 August 2021
Business Wire
PennyStocks
Pulse2
Monday, 16 August 2021
InvestorPlace
  • What's the price of NanoVibronix stock today?

    One share of NanoVibronix stock can currently be purchased for approximately $5.82.

  • When is NanoVibronix's next earnings date?

    Unfortunately, NanoVibronix's (NAOV) next earnings date is currently unknown.

  • Does NanoVibronix pay dividends?

    No, NanoVibronix does not pay dividends.

  • How much money does NanoVibronix make?

    NanoVibronix has a market capitalization of 2.09M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 203.59% to 2.28M US dollars.

  • What is NanoVibronix's stock symbol?

    NanoVibronix, Inc. is traded on the NASDAQ under the ticker symbol "NAOV".

  • What is NanoVibronix's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of NanoVibronix?

    Shares of NanoVibronix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are NanoVibronix's key executives?

    NanoVibronix's management team includes the following people:

    • Mr. Brian M. Murphy Chief Executive Officer & Director(age: 68, pay: $321,000)
    • Mr. Stephen R. Brown CPA, CPA Chief Financial Officer & Accounting Officer(age: 69, pay: $207,500)
  • How many employees does NanoVibronix have?

    As Jul 2024, NanoVibronix employs 10 workers, which is 11% more then previous quarter.

  • When NanoVibronix went public?

    NanoVibronix, Inc. is publicly traded company for more then 10 years since IPO on 28 May 2015.

  • What is NanoVibronix's official website?

    The official website for NanoVibronix is nanovibronix.com.

  • Where are NanoVibronix's headquarters?

    NanoVibronix is headquartered at 525 Executive Boulevard, Elmsford, NY.

  • How can i contact NanoVibronix?

    NanoVibronix's mailing address is 525 Executive Boulevard, Elmsford, NY and company can be reached via phone at +91 42333004.

NanoVibronix company profile:

NanoVibronix, Inc.

nanovibronix.com
Exchange:

NASDAQ

Full time employees:

10

Industry:

Medical - Devices

Sector:

Healthcare

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.

525 Executive Boulevard
Elmsford, NY 10523

CIK: 0001326706
ISIN: US63008J6038
CUSIP: 63008J108